Maternal Fructose Intake Exacerbates Cardiac Remodeling in Offspring with Ventricular Pressure Overload

Steve Leu1,2, Kay L H Wu1, Wei-Chia Lee3

  • 1Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833401, Taiwan.

Nutrients
|September 28, 2021
PubMed

Insights

Excessive maternal fructose intake during pregnancy and lactation exacerbates cardiac remodeling in offspring subjected to pressure overload. This developmental programming increases fibrosis and oxidative stress, impacting cardiac gene expression.

Area of Science:

  • Cardiovascular Physiology
  • Developmental Programming
  • Nutritional Science

Background:

  • Metabolic syndrome and cardiovascular diseases can arise from developmental programming influenced by prenatal stress.
  • Maternal nutrition during critical developmental periods significantly impacts offspring health outcomes.

Purpose of the Study:

  • To investigate the impact of excessive maternal fructose exposure during pregnancy and lactation on cardiac development and pressure overload-induced cardiac hypertrophy in rat offspring.

Main Methods:

  • A rat model was used, with maternal fructose exposure during gestation and lactation.
  • Offspring underwent transverse aortic constriction (TAC) at 3 months to induce cardiac pressure overload.
  • Echocardiography, histopathology, and molecular analyses (NGS, RT-PCR) were performed post-TAC.

Main Results:

  • Maternal fructose exposure (MFE) increased heart weight and cardiac wall thickness in TAC offspring.
  • MFE exacerbated myocardial fibrosis and oxidative stress in TAC offspring.
  • MFE modulated cardiac hypertrophy-associated gene expression and upregulated p38-MAPK signaling.

Conclusions:

  • Maternal fructose intake during pregnancy and lactation negatively impacts offspring cardiac development.
  • MFE worsens pressure overload-induced cardiac remodeling, fibrosis, and oxidative stress.
  • Prenatal nutritional interventions are crucial for preventing long-term cardiovascular consequences.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
104
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
94